Donafenib suppresses glioblastoma progression: potential enhancement of therapeutic response in TMZ-resistant models. - Yazici E; Gezen A; Kalay M; Kocak O; Oylumlu E; Simsek E; Tanriover G (Naunyn-Schmiedeberg's archives of pharmacology, 2026)